▶ 調査レポート

ユビキチンプロテアソームの世界市場(~2026年)

• 英文タイトル:Global Ubiquitin Proteasome Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ユビキチンプロテアソームの世界市場(~2026年) / Global Ubiquitin Proteasome Market Size, Status and Forecast 2020-2026 / MRC2-11QY04917資料のイメージです。• レポートコード:MRC2-11QY04917
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はユビキチンプロテアソームのグローバル市場について調査・分析したレポートです。種類別(ベルケイド、キプロリス)市場規模、用途別(がん、神経変性疾患、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ユビキチンプロテアソームの競争状況、市場シェア
・世界のユビキチンプロテアソーム市場:種類別市場規模 2015年-2020年(ベルケイド、キプロリス)
・世界のユビキチンプロテアソーム市場:種類別市場規模予測 2021年-2026年(ベルケイド、キプロリス)
・世界のユビキチンプロテアソーム市場:用途別市場規模 2015年-2020年(がん、神経変性疾患、その他)
・世界のユビキチンプロテアソーム市場:用途別市場規模予測 2021年-2026年(がん、神経変性疾患、その他)
・北米のユビキチンプロテアソーム市場分析:米国、カナダ
・ヨーロッパのユビキチンプロテアソーム市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのユビキチンプロテアソーム市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のユビキチンプロテアソーム市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのユビキチンプロテアソーム市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Johnson&Johnson、F.Hoffmann-La Roche、Novelix Pharmaceuticals、GlaxoSmithKline、Onyx Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Ubiquitin Proteasome Market
The global Ubiquitin Proteasome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Ubiquitin Proteasome Scope and Market Size
Ubiquitin Proteasome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ubiquitin Proteasome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Johnson&Johnson
F.Hoffmann-La Roche
Novelix Pharmaceuticals
GlaxoSmithKline
Onyx Pharmaceuticals

Market segment by Type, the product can be split into
Velcade
Kyprolis
Market segment by Application, split into
Cancers
Neurodegenerative Disorders
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ubiquitin Proteasome Revenue
1.4 Market by Type
1.4.1 Global Ubiquitin Proteasome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Velcade
1.4.3 Kyprolis
1.5 Market by Application
1.5.1 Global Ubiquitin Proteasome Market Share by Application: 2020 VS 2026
1.5.2 Cancers
1.5.3 Neurodegenerative Disorders
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Ubiquitin Proteasome Market Perspective (2015-2026)
2.2 Global Ubiquitin Proteasome Growth Trends by Regions
2.2.1 Ubiquitin Proteasome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ubiquitin Proteasome Historic Market Share by Regions (2015-2020)
2.2.3 Ubiquitin Proteasome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ubiquitin Proteasome Market Growth Strategy
2.3.6 Primary Interviews with Key Ubiquitin Proteasome Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Ubiquitin Proteasome Players by Market Size
3.1.1 Global Top Ubiquitin Proteasome Players by Revenue (2015-2020)
3.1.2 Global Ubiquitin Proteasome Revenue Market Share by Players (2015-2020)
3.1.3 Global Ubiquitin Proteasome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ubiquitin Proteasome Market Concentration Ratio
3.2.1 Global Ubiquitin Proteasome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ubiquitin Proteasome Revenue in 2019
3.3 Ubiquitin Proteasome Key Players Head office and Area Served
3.4 Key Players Ubiquitin Proteasome Product Solution and Service
3.5 Date of Enter into Ubiquitin Proteasome Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Ubiquitin Proteasome Historic Market Size by Type (2015-2020)
4.2 Global Ubiquitin Proteasome Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Ubiquitin Proteasome Market Size by Application (2015-2020)
5.2 Global Ubiquitin Proteasome Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Ubiquitin Proteasome Market Size (2015-2020)
6.2 Ubiquitin Proteasome Key Players in North America (2019-2020)
6.3 North America Ubiquitin Proteasome Market Size by Type (2015-2020)
6.4 North America Ubiquitin Proteasome Market Size by Application (2015-2020)

7 Europe
7.1 Europe Ubiquitin Proteasome Market Size (2015-2020)
7.2 Ubiquitin Proteasome Key Players in Europe (2019-2020)
7.3 Europe Ubiquitin Proteasome Market Size by Type (2015-2020)
7.4 Europe Ubiquitin Proteasome Market Size by Application (2015-2020)

8 China
8.1 China Ubiquitin Proteasome Market Size (2015-2020)
8.2 Ubiquitin Proteasome Key Players in China (2019-2020)
8.3 China Ubiquitin Proteasome Market Size by Type (2015-2020)
8.4 China Ubiquitin Proteasome Market Size by Application (2015-2020)

9 Japan
9.1 Japan Ubiquitin Proteasome Market Size (2015-2020)
9.2 Ubiquitin Proteasome Key Players in Japan (2019-2020)
9.3 Japan Ubiquitin Proteasome Market Size by Type (2015-2020)
9.4 Japan Ubiquitin Proteasome Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Ubiquitin Proteasome Market Size (2015-2020)
10.2 Ubiquitin Proteasome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ubiquitin Proteasome Market Size by Type (2015-2020)
10.4 Southeast Asia Ubiquitin Proteasome Market Size by Application (2015-2020)

11 India
11.1 India Ubiquitin Proteasome Market Size (2015-2020)
11.2 Ubiquitin Proteasome Key Players in India (2019-2020)
11.3 India Ubiquitin Proteasome Market Size by Type (2015-2020)
11.4 India Ubiquitin Proteasome Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Ubiquitin Proteasome Market Size (2015-2020)
12.2 Ubiquitin Proteasome Key Players in Central & South America (2019-2020)
12.3 Central & South America Ubiquitin Proteasome Market Size by Type (2015-2020)
12.4 Central & South America Ubiquitin Proteasome Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Johnson&Johnson
13.1.1 Johnson&Johnson Company Details
13.1.2 Johnson&Johnson Business Overview
13.1.3 Johnson&Johnson Ubiquitin Proteasome Introduction
13.1.4 Johnson&Johnson Revenue in Ubiquitin Proteasome Business (2015-2020))
13.1.5 Johnson&Johnson Recent Development
13.2 F.Hoffmann-La Roche
13.2.1 F.Hoffmann-La Roche Company Details
13.2.2 F.Hoffmann-La Roche Business Overview
13.2.3 F.Hoffmann-La Roche Ubiquitin Proteasome Introduction
13.2.4 F.Hoffmann-La Roche Revenue in Ubiquitin Proteasome Business (2015-2020)
13.2.5 F.Hoffmann-La Roche Recent Development
13.3 Novelix Pharmaceuticals
13.3.1 Novelix Pharmaceuticals Company Details
13.3.2 Novelix Pharmaceuticals Business Overview
13.3.3 Novelix Pharmaceuticals Ubiquitin Proteasome Introduction
13.3.4 Novelix Pharmaceuticals Revenue in Ubiquitin Proteasome Business (2015-2020)
13.3.5 Novelix Pharmaceuticals Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Ubiquitin Proteasome Introduction
13.4.4 GlaxoSmithKline Revenue in Ubiquitin Proteasome Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Onyx Pharmaceuticals
13.5.1 Onyx Pharmaceuticals Company Details
13.5.2 Onyx Pharmaceuticals Business Overview
13.5.3 Onyx Pharmaceuticals Ubiquitin Proteasome Introduction
13.5.4 Onyx Pharmaceuticals Revenue in Ubiquitin Proteasome Business (2015-2020)
13.5.5 Onyx Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Ubiquitin Proteasome Key Market Segments
Table 2. Key Players Covered: Ranking by Ubiquitin Proteasome Revenue
Table 3. Ranking of Global Top Ubiquitin Proteasome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ubiquitin Proteasome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Velcade
Table 6. Key Players of Kyprolis
Table 7. Global Ubiquitin Proteasome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Ubiquitin Proteasome Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Ubiquitin Proteasome Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Ubiquitin Proteasome Market Share by Regions (2015-2020)
Table 11. Global Ubiquitin Proteasome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Ubiquitin Proteasome Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Ubiquitin Proteasome Market Growth Strategy
Table 17. Main Points Interviewed from Key Ubiquitin Proteasome Players
Table 18. Global Ubiquitin Proteasome Revenue by Players (2015-2020) (Million US$)
Table 19. Global Ubiquitin Proteasome Market Share by Players (2015-2020)
Table 20. Global Top Ubiquitin Proteasome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ubiquitin Proteasome as of 2019)
Table 21. Global Ubiquitin Proteasome by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ubiquitin Proteasome Product Solution and Service
Table 24. Date of Enter into Ubiquitin Proteasome Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ubiquitin Proteasome Market Size by Type (2015-2020) (Million US$)
Table 27. Global Ubiquitin Proteasome Market Size Share by Type (2015-2020)
Table 28. Global Ubiquitin Proteasome Revenue Market Share by Type (2021-2026)
Table 29. Global Ubiquitin Proteasome Market Size Share by Application (2015-2020)
Table 30. Global Ubiquitin Proteasome Market Size by Application (2015-2020) (Million US$)
Table 31. Global Ubiquitin Proteasome Market Size Share by Application (2021-2026)
Table 32. North America Key Players Ubiquitin Proteasome Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Ubiquitin Proteasome Market Share (2019-2020)
Table 34. North America Ubiquitin Proteasome Market Size by Type (2015-2020) (Million US$)
Table 35. North America Ubiquitin Proteasome Market Share by Type (2015-2020)
Table 36. North America Ubiquitin Proteasome Market Size by Application (2015-2020) (Million US$)
Table 37. North America Ubiquitin Proteasome Market Share by Application (2015-2020)
Table 38. Europe Key Players Ubiquitin Proteasome Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Ubiquitin Proteasome Market Share (2019-2020)
Table 40. Europe Ubiquitin Proteasome Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Ubiquitin Proteasome Market Share by Type (2015-2020)
Table 42. Europe Ubiquitin Proteasome Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Ubiquitin Proteasome Market Share by Application (2015-2020)
Table 44. China Key Players Ubiquitin Proteasome Revenue (2019-2020) (Million US$)
Table 45. China Key Players Ubiquitin Proteasome Market Share (2019-2020)
Table 46. China Ubiquitin Proteasome Market Size by Type (2015-2020) (Million US$)
Table 47. China Ubiquitin Proteasome Market Share by Type (2015-2020)
Table 48. China Ubiquitin Proteasome Market Size by Application (2015-2020) (Million US$)
Table 49. China Ubiquitin Proteasome Market Share by Application (2015-2020)
Table 50. Japan Key Players Ubiquitin Proteasome Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Ubiquitin Proteasome Market Share (2019-2020)
Table 52. Japan Ubiquitin Proteasome Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Ubiquitin Proteasome Market Share by Type (2015-2020)
Table 54. Japan Ubiquitin Proteasome Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Ubiquitin Proteasome Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Ubiquitin Proteasome Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Ubiquitin Proteasome Market Share (2019-2020)
Table 58. Southeast Asia Ubiquitin Proteasome Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Ubiquitin Proteasome Market Share by Type (2015-2020)
Table 60. Southeast Asia Ubiquitin Proteasome Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Ubiquitin Proteasome Market Share by Application (2015-2020)
Table 62. India Key Players Ubiquitin Proteasome Revenue (2019-2020) (Million US$)
Table 63. India Key Players Ubiquitin Proteasome Market Share (2019-2020)
Table 64. India Ubiquitin Proteasome Market Size by Type (2015-2020) (Million US$)
Table 65. India Ubiquitin Proteasome Market Share by Type (2015-2020)
Table 66. India Ubiquitin Proteasome Market Size by Application (2015-2020) (Million US$)
Table 67. India Ubiquitin Proteasome Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Ubiquitin Proteasome Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Ubiquitin Proteasome Market Share (2019-2020)
Table 70. Central & South America Ubiquitin Proteasome Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Ubiquitin Proteasome Market Share by Type (2015-2020)
Table 72. Central & South America Ubiquitin Proteasome Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Ubiquitin Proteasome Market Share by Application (2015-2020)
Table 74. Johnson&Johnson Company Details
Table 75. Johnson&Johnson Business Overview
Table 76. Johnson&Johnson Product
Table 77. Johnson&Johnson Revenue in Ubiquitin Proteasome Business (2015-2020) (Million US$)
Table 78. Johnson&Johnson Recent Development
Table 79. F.Hoffmann-La Roche Company Details
Table 80. F.Hoffmann-La Roche Business Overview
Table 81. F.Hoffmann-La Roche Product
Table 82. F.Hoffmann-La Roche Revenue in Ubiquitin Proteasome Business (2015-2020) (Million US$)
Table 83. F.Hoffmann-La Roche Recent Development
Table 84. Novelix Pharmaceuticals Company Details
Table 85. Novelix Pharmaceuticals Business Overview
Table 86. Novelix Pharmaceuticals Product
Table 87. Novelix Pharmaceuticals Revenue in Ubiquitin Proteasome Business (2015-2020) (Million US$)
Table 88. Novelix Pharmaceuticals Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Product
Table 92. GlaxoSmithKline Revenue in Ubiquitin Proteasome Business (2015-2020) (Million US$)
Table 93. GlaxoSmithKline Recent Development
Table 94. Onyx Pharmaceuticals Company Details
Table 95. Onyx Pharmaceuticals Business Overview
Table 96. Onyx Pharmaceuticals Product
Table 97. Onyx Pharmaceuticals Revenue in Ubiquitin Proteasome Business (2015-2020) (Million US$)
Table 98. Onyx Pharmaceuticals Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ubiquitin Proteasome Market Share by Type: 2020 VS 2026
Figure 2. Velcade Features
Figure 3. Kyprolis Features
Figure 4. Global Ubiquitin Proteasome Market Share by Application: 2020 VS 2026
Figure 5. Cancers Case Studies
Figure 6. Neurodegenerative Disorders Case Studies
Figure 7. Others Case Studies
Figure 8. Ubiquitin Proteasome Report Years Considered
Figure 9. Global Ubiquitin Proteasome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Ubiquitin Proteasome Market Share by Regions: 2020 VS 2026
Figure 11. Global Ubiquitin Proteasome Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Ubiquitin Proteasome Market Share by Players in 2019
Figure 14. Global Top Ubiquitin Proteasome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ubiquitin Proteasome as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Ubiquitin Proteasome Revenue in 2019
Figure 16. North America Ubiquitin Proteasome Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Ubiquitin Proteasome Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Ubiquitin Proteasome Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Ubiquitin Proteasome Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Ubiquitin Proteasome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Ubiquitin Proteasome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Ubiquitin Proteasome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed